Literature DB >> 33522943

Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet's disease in Japan.

Yutaro Soejima1, Yohei Kirino2, Mitsuhiro Takeno3, Michiko Kurosawa4, Masaki Takeuchi5, Ryusuke Yoshimi1, Yumiko Sugiyama6, Shigeru Ohno6, Yukiko Asami7, Akiko Sekiguchi8, Toshihisa Igarashi9, Shohei Nagaoka10, Yoshiaki Ishigatsubo11, Hideaki Nakajima1, Nobuhisa Mizuki5.   

Abstract

BACKGROUND: We hypothesized that Behçet's disease (BD) consists of several clinical subtypes with different severity, resulting in heterogeneity of the disease. Here, we conducted a study to identify clinical clusters of BD.
METHODS: A total of 657 patients registered in the Yokohama City University (YCU) regional BD registry between 1990 and 2018, as well as 6754 patients who were initially registered in the Japanese Ministry of Health, Labour and Welfare (MHLW) database between 2003 and 2014, were investigated. The YCU registry data regarding the clinical manifestations of BD, human leukocyte antigen (HLA) status, treatments, and hospitalizations were analyzed first, followed by similar analyses of the MHLW for validation. A hierarchical cluster analysis was independently performed in both patient groups.
RESULTS: A hierarchical cluster analysis determined five independent clinical clusters in the YCU cohort. Individual counterparts of the YCU clusters were confirmed in the MHLW registry. Recent phenotypical evolutions of BD in Japan, such as increased gastrointestinal (GI) involvement, reduced complete type according to the Japan Criteria, and reduced HLA-B51 positivity were associated with chronologically changing proportions of the clinical clusters.
CONCLUSIONS: In this study, we identified independent clinical clusters among BD patients in Japan and found that the proportion of each cluster varied over time. We propose five independent clusters namely "mucocutaneous", "mucocutaneous with arthritis", "neuro", "GI", and "eye."

Entities:  

Keywords:  Behçet’s disease; Cluster analysis; Intestinal manifestation

Year:  2021        PMID: 33522943      PMCID: PMC7851921          DOI: 10.1186/s13075-020-02406-6

Source DB:  PubMed          Journal:  Arthritis Res Ther        ISSN: 1478-6354            Impact factor:   5.156


  50 in total

1.  2018 update of the EULAR recommendations for the management of Behçet's syndrome.

Authors:  Gulen Hatemi; Robin Christensen; Dongsik Bang; Bahram Bodaghi; Aykut Ferhat Celik; Farida Fortune; Julien Gaudric; Ahmet Gul; Ina Kötter; Pietro Leccese; Alfred Mahr; Robert Moots; Yesim Ozguler; Jutta Richter; David Saadoun; Carlo Salvarani; Francesco Scuderi; Petros P Sfikakis; Aksel Siva; Miles Stanford; Ilknur Tugal-Tutkun; Richard West; Sebahattin Yurdakul; Ignazio Olivieri; Hasan Yazici
Journal:  Ann Rheum Dis       Date:  2018-04-06       Impact factor: 19.103

2.  Behçet's syndrome patients exhibit specific microbiome signature.

Authors:  Clarissa Consolandi; Silvia Turroni; Giacomo Emmi; Marco Severgnini; Jessica Fiori; Clelia Peano; Elena Biagi; Alessia Grassi; Simone Rampelli; Elena Silvestri; Manuela Centanni; Fabio Cianchi; Roberto Gotti; Lorenzo Emmi; Patrizia Brigidi; Nicola Bizzaro; Gianluca De Bellis; Domenico Prisco; Marco Candela; Mario M D'Elios
Journal:  Autoimmun Rev       Date:  2014-11-27       Impact factor: 9.754

Review 3.  Behçet syndrome: a contemporary view.

Authors:  Hasan Yazici; Emire Seyahi; Gulen Hatemi; Yusuf Yazici
Journal:  Nat Rev Rheumatol       Date:  2018-01-03       Impact factor: 20.543

4.  Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease.

Authors:  Elaine F Remmers; Fulya Cosan; Yohei Kirino; Michael J Ombrello; Neslihan Abaci; Colleen Satorius; Julie M Le; Barbara Yang; Benjamin D Korman; Aris Cakiris; Oznur Aglar; Zeliha Emrence; Hulya Azakli; Duran Ustek; Ilknur Tugal-Tutkun; Gulsen Akman-Demir; Wei Chen; Christopher I Amos; Michael B Dizon; Afet Akdag Kose; Gulsevim Azizlerli; Burak Erer; Oliver J Brand; Virginia G Kaklamani; Phaedon Kaklamanis; Eldad Ben-Chetrit; Miles Stanford; Farida Fortune; Marwen Ghabra; William E R Ollier; Young-Hun Cho; Dongsik Bang; John O'Shea; Graham R Wallace; Massimo Gadina; Daniel L Kastner; Ahmet Gül
Journal:  Nat Genet       Date:  2010-07-11       Impact factor: 38.330

5.  Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study.

Authors:  Gulen Hatemi; Izzet Fresko; Koray Tascilar; Hasan Yazici
Journal:  Arthritis Rheum       Date:  2008-05

6.  Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region.

Authors:  Bo Ding; Leonid Padyukov; Emeli Lundström; Mark Seielstad; Robert M Plenge; Jorge R Oksenberg; Peter K Gregersen; Lars Alfredsson; Lars Klareskog
Journal:  Arthritis Rheum       Date:  2009-01

7.  Are clusters of patients with distinct clinical expression present in Behçet's disease?

Authors:  A Arida; G Vaiopoulos; N Markomichelakis; P Kaklamanis; P P Sfikakis
Journal:  Clin Exp Rheumatol       Date:  2009 Mar-Apr       Impact factor: 4.473

8.  The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey.

Authors:  Yuki Mizuki; Nobuyuki Horita; Yukihiro Horie; Masaki Takeuchi; Takehito Ishido; Ryuta Mizuki; Tatsukata Kawagoe; Etsuko Shibuya; Kentaro Yuda; Mizuho Ishido; Kaoru Minegishi; Ryusuke Yoshimi; Yohei Kirino; Shingo Kato; Jun Arimoto; Takeshi Fukumoto; Michiko Kurosawa; Nobuyoshi Kitaichi; Mitsuhiro Takeno; Takeshi Kaneko; Nobuhisa Mizuki
Journal:  Mod Rheumatol       Date:  2019-08-06       Impact factor: 3.023

9.  Clinical manifestations of Behçet's disease depending on sex and age: results from Japanese nationwide registration.

Authors:  Takehito Ishido; Nobuyuki Horita; Masaki Takeuchi; Tatsukata Kawagoe; Etsuko Shibuya; Takahiro Yamane; Takahiko Hayashi; Akira Meguro; Mizuho Ishido; Kaoru Minegishi; Ryusuke Yoshimi; Yohei Kirino; Shingo Kato; Jun Arimoto; Yoshiaki Ishigatsubo; Mitsuhiro Takeno; Michiko Kurosawa; Takeshi Kaneko; Nobuhisa Mizuki
Journal:  Rheumatology (Oxford)       Date:  2017-11-01       Impact factor: 7.580

10.  Identification of genetic susceptibility loci for intestinal Behçet's disease.

Authors:  Seung Won Kim; Yoon Suk Jung; Jae Bum Ahn; Eun-Soon Shin; Hui Won Jang; Hyun Jung Lee; Tae Il Kim; Do Young Kim; Dongsik Bang; Won Ho Kim; Jae Hee Cheon
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

View more
  5 in total

Review 1.  Behcet's Disease: An In-Depth Review about Pathogenesis, Gastrointestinal Manifestations, and Management.

Authors:  Anthony Nguyen; Shubhra Upadhyay; Muhammad Ali Javaid; Abdul Moiz Qureshi; Shahan Haseeb; Nismat Javed; Christopher Cormier; Asif Farooq; Abu Baker Sheikh
Journal:  Inflamm Intest Dis       Date:  2021-11-04

Review 2.  The Roles of Monocytes and Macrophages in Behçet's Disease With Focus on M1 and M2 Polarization.

Authors:  Lisa Hirahara; Kaoru Takase-Minegishi; Yohei Kirino; Yuki Iizuka-Iribe; Yutaro Soejima; Ryusuke Yoshimi; Hideaki Nakajima
Journal:  Front Immunol       Date:  2022-03-11       Impact factor: 7.561

3.  Clinical heterogeneity of ocular Behçet's syndrome versus intestinal Behçet's syndrome: a cross-sectional study from Shanghai Behçet's syndrome database.

Authors:  Cheng-Cheng Hou; Dan Luo; Hua-Fang Bao; Jing-Fen Ye; Hai-Fen Ma; Yan Shen; Jun Zou; Jian-Long Guan
Journal:  Arthritis Res Ther       Date:  2022-04-29       Impact factor: 5.606

Review 4.  Behçet's Disease-Do Microbiomes and Genetics Collaborate in Pathogenesis?

Authors:  Nafeesa Mehmood; Liying Low; Graham R Wallace
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

Review 5.  The association of Behçet's syndrome with HLA-B51 as understood in 2021.

Authors:  Mitsuhiro Takeno
Journal:  Curr Opin Rheumatol       Date:  2022-01-01       Impact factor: 5.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.